[Poster] S2

[P-S2-22] SYNTHESIS AND EVALUATION OF ASTATINE-211-LABELED FAP-INHIBITOR RADIOPHARMACEUTICALS

*Masayuki Takamatsu^1,2, Atsushi Shimoyama^1,2, Ayaka Aso¹, Taketo Toda¹, Jumpei Ueno¹, Koki Mayusumi¹, Kazuya Kabayama², Yuichiro Kadonaga², Yoshifumi Shirakami², Tadashi Watabe^2,3, Taku Yoshiya⁴, Kazuhiro Ooe², Atsushi Toyoshima², Hiromitsu Haba⁵, Jens Cardinale⁶, Frederik Lars Giesel⁶, Kazuko Kaneda Nakashima², Koichi Fukase^1,2 (1. Grad. Sch. Sci., The Univ. of Osaka (Japan), 2. IRS, Osaka Univ., The Univ. of Osaka (Japan), 3. Grad. Sch. Med., The Univ. of Osaka (Japan), 4. Peptide Institute, Inc. (Japan), 5. RIKEN (Japan), 6. University Hospital Düsseldorf (Germany))

Keywords:

Targeted alpha therapy,astatine-211,Fibroblast activation proteins,nuclear medicine,Biodistribution